2023 annual financial data
Gain Therapeutics 2023 Net margin
Direct answer
Net margin was -40,354.33%.
Operating income was -22,253,133 USD and net income was -22,267,520 USD.
Operating cash flow was -18,865,873 USD.
Get free Gain Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 55,180 USD
- Operating income
- -22,253,133 USD
- Net income
- -22,267,520 USD
- Operating cash flow
- -18,865,873 USD